From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA reviewers recommend against approval for Novartis heart failure drug

from Forbes

Ahead of an important advisory panel FDA reviewers have recommended against approval of a novel drug for acute heart failure from Novartis. The once highly-promising drug, which received a "breakthrough therapy" designation from the FDA last year, was turned down for approval in Europe earlier this year. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063